Aug 06, 2020

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear, according to presenters at the Cardiometabolic Health Congress. A debate between Ph. Gabriel Steg, MD, professor of cardiology at Paris Diderot University and director of the coronary care unit at Hospital Bichat-Claude Bernard, and

Proceed to the page:

Similar Articles Added Earlier

Similar Articles Added Today

Most Recent Articles

Latest Links Processed